Nurse Practitioner Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Christine Kessler

Nurse Practitioner, Adult Health Fort Belvoir, VA Nurse Practitioner

NPI 1891835096 CMS profile 11213613

9501 Farrell Rd, Dewitt Family Health Center, Internal Medicine, Fort Belvoir, VA 22060

Open in the dashboard

General payments

$107,075

151 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Christine Kessler of Fort Belvoir, VA is reported in the CMS Open Payments database as having received $107,075 across 151 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Adult Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $25,456 34
2023 General $29,679 43
2022 General $1,597 7
2021 General $50,343 67

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christine Kessler
  • Nurse Practitioner, Adult Health median
  • Middle half of Nurse Practitioner, Adult Health
  • National median

In program year 2025, general payments to Christine Kessler were reported at $0. Among 12,696 Nurse Practitioner, Adult Health profiles paid that year, the median was $184 and the middle half received between $59 and $580.

Show as a table
Year Christine Kessler Nurse Practitioner, Adult Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $50,343 $138 $43–$438 $132
2022 $1,597 $165 $54–$494 $149
2023 $29,679 $178 $61–$549 $160
2024 $25,456 $186 $62–$575 $164
2025 $0 $184 $59–$580 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Novo Nordisk Inc $99,306 139 payments
  2. Acella Pharmaceuticals, LLC $5,780 4 payments
  3. Zealand Pharma US, Inc. $1,800 5 payments
  4. Corcept Therapeutics $87 1 payment
  5. Abbott Laboratories $64 1 payment
  6. Otsuka Pharmaceutical Development & Commercialization, Inc. $39 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $81,229 40 payments
  2. Travel and Lodging $17,953 75 payments
  3. Food and Beverage $3,005 31 payments
  4. Honoraria $2,450 1 payment
  5. Consulting Fee $2,415 3 payments
  6. Education $22 1 payment
Products named General payments · program years 2021–2024
  1. Wegovy $76,797 107 payments
  2. Saxenda $20,094 29 payments
  3. NP Thyroid 60 $5,780 4 payments
  4. RYBELSUS $1,380 2 payments
  5. ZEGALOGUE Diabetes $1,375 4 payments
  6. ZEGALOGUE 1 $425 1 payment
  7. Korlym $87 1 payment
  8. FreeStyle Libre 2 $64 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

151 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Adult Health in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record